<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Moderna Releases 94.5% Efficacious Clinical Trial Results
Image Overlay - Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna has released clinical trial results that indicate its vaccine is 94.5% effective in preventing the coronavirus. A total of 30,000 volunteers were recruited for the study – half received two doses of the vaccine 28 days apart while the other 50% received a placebo. Of those, 95 participants contracted COVID-19, though only 5 were from the group that received the vaccine. Yourway has an advanced direct-to-patient program to help encourage clinical trial retention and patient access, especially during various country-wide lockdowns.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?